Investors of Alexion Pharmaceuticals (ALXN) have voted in favor of the company’s acquisition by AstraZeneca. Pending regulatory approvals, the transaction is expected to …
After a stock takes a tumble, wait just a minute before you count it out. While falling share prices could be a sign …
The calendar might have flipped to 2020, but that doesn’t mean everything has changed. Investors are still scouring the Street in search of …
One area of the market that has been gaining steam: biotech stocks. A flurry of deals, FDA approvals, and recent innovations in the …
When billionaire financier Ray Dalio makes a move, Wall Street pays attention. Dalio, who got his start working on the floor of the …
When it comes to stocks that can shoot up overnight, biotechs are the name of the game. This group’s extreme volatility lies in …
TipRanks has built a reputation on collecting the right information for investors looking to make informed decisions on their stock purchases. The database …
In a previous article, I talked about the so-called patent cliff and the correlation to the pace of mergers and acquisitions in the pharma …
Analysts are weighing in on Ophthotech Corp (NASDAQ:OPHT) and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), as shares of both healthcare firms fell sharply today, hitting new …
Credit Suisse analyst Alethia Young upgraded Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Neutral to Outperform with a price target of $165, marking a 32.
